Is there a limit to the normality of blood products?
作者信息
Hughes W G
出版信息
Hematol J. 2001;2(3):212. doi: 10.1038/sj.thj.6200100.
PMID:11920249
Abstract
摘要
相似文献
1
Is there a limit to the normality of blood products?血液制品的正常标准有上限吗？
Hematol J. 2001;2(3):212. doi: 10.1038/sj.thj.6200100.
2
Management of scarce resources in blood services in developing countries.发展中国家血液服务中稀缺资源的管理。
Vox Sang. 2002 Aug;83 Suppl 1:137-40. doi: 10.1111/j.1423-0410.2002.tb05287.x.
3
The cost-effectiveness of pathogen reduction technology as assessed using a multiple risk reduction model.采用多重风险降低模型评估病原体减少技术的成本效益。
Transfusion. 2010 Nov;50(11):2461-73. doi: 10.1111/j.1537-2995.2010.02704.x.
4
Blood safety in developing countries.发展中国家的血液安全。
Vox Sang. 1994;67(4):377-81. doi: 10.1111/j.1423-0410.1994.tb01277.x.
5
ISBT Board response to the Dublin consensus statement.国际输血协会理事会对都柏林共识声明的回应。
Vox Sang. 2011 Feb;100(2):250-1. doi: 10.1111/j.1423-0410.2010.01416.x. Epub 2010 Oct 15.
6
Is there a limit to the normality of blood products?血液制品的正常标准有上限吗？
Hematol J. 2000;1(5):291. doi: 10.1038/sj.thj.6200059.
7
The Dublin Consensus Statement on vital issues relating to the collection of blood and plasma and the manufacture of plasma products. PLUS.关于血液和血浆采集以及血浆制品生产相关重要问题的都柏林共识声明。附加内容。
Vox Sang. 2010 Apr;98(3 Pt 2):447-50. doi: 10.1111/j.1423-0410.2010.01310.x. Epub 2010 Feb 11.
8
The quality of blood starts with its collection.
Vox Sang. 1994;67 Suppl 3:77-9. doi: 10.1111/j.1423-0410.1994.tb04548.x.
9
Screening blood for viral genomes: which way to go?筛查血液中的病毒基因组：何去何从？
Transfus Med. 1998 Mar;8(1):5-7. doi: 10.1046/j.1365-3148.1998.00131.x.
10
Ask the patients.询问患者。
Tex Med. 2004 Mar;100(3):8.
Zotero 插件